Medical System Network CoTSE:4350 -0.86%64 EBITDA Margin % is 11.97% as of Mar. 2026, which is 124% above its 10-year median of 5.35. GuruFocus rates TSE:4350 with a GF Score™ of 64/100 and a GF Value™ of 円521.78 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Medical System Network Co ranks worse than 64.82% on this metric.
Medical System Network Co (TSE:4350) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Medical System Network Co EBITDA Margin % Related Terms
Medical System Network Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical System Network Co EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Medical System Network Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical System Network Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medical System Network Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Medical System Network Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical System Network Co (TSE:4350) has a EBITDA Margin % of 11.97% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medical System Network Co and its competitors. This is 124% above median its historical median of 5.35. Over the past decade, Medical System Network Co's EBITDA Margin % has ranged from 3.12 to 6.88. According to the industry distribution chart, Medical System Network Co ranks #433 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 64.8%.
Is Medical System Network Co's EBITDA Margin % too high?
Medical System Network Co's current EBITDA Margin % of 11.97% is 124% above median its 10-year median of 5.35. Over the past 10 years, this metric has ranged from a low of 3.12 to a high of 6.88. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Medical System Network Co's value of 11.97% is 17.2% above this industry median. Based on the distribution chart, Medical System Network Co ranks #433 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Medical System Network Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical System Network Co's EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Medical System Network Co ranks #433 out of 668 companies for EBITDA Margin %. This places Medical System Network Co in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Medical System Network Co's value of 11.97% is 17.2% above this benchmark. Historically, Medical System Network Co's own EBITDA Margin % has ranged from 3.12 to 6.88 over the past decade. While the company's 10-year median is 5.35 vs. the industry median of 10.21, Medical System Network Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical System Network Co's current EBITDA Margin % of 11.97% is 17.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medical System Network Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical System Network Co's current EBITDA Margin % is 11.97%, which is 124% above median its own 10-year median of 5.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical System Network Co stock overvalued right now?
Based on GuruFocus' analysis, Medical System Network Co (TSE:4350) is currently considered Modestly Undervalued. The stock's GF Value™ is 円521.78, compared to a current price of 円461.00 — trading 11.6% below its estimated fair value. The current EBITDA Margin % is 11.97%, which is 124% above median its 10-year median of 5.35 and 17.2% above the Healthcare Providers & Services industry median of 10.21. Medical System Network Co's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medical System Network Co (TSE:4350), the current EBITDA Margin % is 11.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical System Network Co (TSE:4350) Overvalued in 2026?
Based on GuruFocus' analysis, Medical System Network Co stock appears to be undervalued.
The current stock price of 円461.00 is trading 11.6% below its estimated GF Value™ of 円521.78.
GuruFocus considers Medical System Network Co to be Modestly Undervalued.
Key valuation signals for TSE:4350:
EBITDA Margin %: 11.97% (124% above median its 10-year median of 5.35)
GF Value™: 円521.78 vs. price of 円461.00 (11.6% below fair value)
Industry Position: 17.2% above the Healthcare Providers & Services median (#433 of 668)
No single metric tells the full story. See the TSE:4350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical System Network Co Ltd is involved in its network business of dispensing pharmacy business. It also operates a network database used by pharmacies to access patients' prescriptions. It operates through the following business divisions: Pharmaceutical Product Network; Dispensing Pharmacy; Leasing and Equipment-related Business; Food Supply business and others.
64GF Score
Get the complete analysis for TSE:4350
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4350 has been successfully added to your 
